London – In a medical leap that could end the long-wait suffering for millions in oncology centers, the UK has begun testing a “revolutionary” drug technology that delivers cancer treatment via a fast-acting injection taking no more than 60 seconds. Obviously, by May 2026, this innovation aims to replace traditional intravenous (IV) infusions—which kept patients tethered to machines for hours—with a smart drug formula injected subcutaneously in mere seconds.
“One Minute”: How Does the New Treatment Change Cancer Patients’ Lives?
Medical reports clarified that the secret behind this technology lies in modifying the chemical formulation of immunotherapy and targeted drugs to make them suitable for direct, rapid injection. Accordingly, patients will no longer need to spend an entire day at the hospital; they can receive the dose and leave immediately. Clearly, the goal transcends “saving time,” aiming to improve quality of life, reduce the psychological stress associated with long chemo sessions, and boost healthcare efficiency by accommodating more patients daily.
“Race Against Time”: Will the Fast Injection Become the New Global Standard?
Specialists believe this move puts the UK at the forefront of the global race to develop “smart treatments.” As a result, clinical results are currently being evaluated to ensure total safety and long-term efficacy compared to traditional methods. In light of this evolution, experts affirm we are approaching an era where cancer treatment becomes a “quick routine procedure,” significantly reducing the immense pressure on hospitals. There are high hopes for this technology’s international adoption in the near future.
